Location Based Technologies : Attorney Letter for FYE 2021

Claire E. Brown [e-mail]

503.802.5731 direct 503.221.1440 main

November 29, 2021

OTC Markets Group Inc.

304 Hudson Street, Second Floor

New York, New York 10013

Re: Location Based Technologies, Inc. Attorney Letter for Disclosure Statements pursuant to Pink Basic Disclosure Guidelines

Ladies and Gentlemen:

The undersigned ("Counsel") has served as counsel to Location Based Technologies, Inc. (the "Issuer") for purposes of rendering this attorney letter ("Letter") to OTC Markets Group, Inc. ("OTC Markets") as to the Issuer's compliance with the Disclosure Statement pursuant to the OTC Pink Basic Disclosure Guidelines. OTC Markets is entitled to rely on the Letter in determining whether the Issuer has made adequate current information publicly available within the meaning of Rule 144(c)(2) under the Securities Act of 1933 (the "Securities Act").

Counsel: (i) is a resident of the United States, (ii) resides in the State of Oregon,

1. is admitted to practice law in the State of Oregon, (iv) is permitted to practice before the Securities and Exchange Commission (the "SEC") and has not been prohibited from practice thereunder, (v) does not beneficially own any securities of the Issuer, (vi) has not received, and does not have an agreement to receive in the future, shares of the Issuer's securities, in payment for services, and (vii) is not now, nor in the past five years, been: (a) the subject of an investigation, hearing, or proceeding by the SEC, the U.S. Commodity Futures Trading Commission (CFTC), the Financial Industry Regulatory Authority (FINRA), or any other federal, state, or foreign regulatory agency; (b) suspended or barred from practicing in any state or jurisdiction, or (c) charged in a civil or criminal case.

Counsel has examined such corporate records and other documents and such questions of law as she considered necessary or appropriate for purposes of rendering this Letter. In connection with the preparation of this Letter, Counsel has reviewed the following specific documents concerning the Issuer and its

November 29, 2021

Page 2

securities (the "Information"), which Information is publicly available through the OTC Disclosure & News Service.

The Information: (i) constitutes "adequate current public information" concerning the Issuer and the shares of common stock of the Issuer (the "Securities") and is "available" within the meaning of Rule 144(c)(2) under the Securities Act;

1. includes all of the information that a broker-dealer would be required to obtain from the Issuer to publish a quotation for the Securities under Rule 15c2- 11 of the Securities Exchange Act of 1934 (the "Exchange Act"), (iii) complies as to form with the OTC Markets Group's Pink Basic Disclosure Guidelines, which are located on the Internet at www.otcmarkets.com; and (iv) has been posted through the OTC Disclosure & News Service.

The person responsible for the preparation of the Issuer's financial statements is Tina Florance, a Certified Public Accountant. Ms. Florance has more than 23 years of accounting experience in the public and private sectors and is licensed in California. The financial statements are not audited.

The Issuer's transfer agent is Broadridge Financial Solutions, Inc., with its address at 2 Gateway Center, 283-299 Market Street, 15th Floor, Newark, NJ 07102. Its telephone number is [phone]. The transfer agent is registered with the SEC. The method used by us to confirm the number of outstanding shares was a review of the Issuer's public filings.

Counsel has: (i) met, via email and remote video conference, with management and all of the directors of the Issuer, namely, (a) David M. Morse (President, CEO, Principal Financial Officer and Director), (b) Greggory S. Haugen (Director), and

1. Desiree C. Meija (Director); (ii) reviewed the Information published by the Issuer through the OTC Disclosure & News Service; and (iii) addressed the Information with management and the Directors of the Issuer and has received confirmation from each of them that they have reviewed the Information and certify that the Information does not contain any untrue statement of material fact or omit to state a material fact that would make the Information not misleading and agree with its contents.

As to matters of fact, Counsel has relied on information obtained from public officials, officers of the Issuer and other sources. Counsel has no reason to believe that such information or sources are not reliable.

To the best knowledge of Counsel, after inquiry of management and the directors of the Issuer, neither the Issuer nor any 5% shareholder of the Issuer nor Counsel is currently under investigation by any federal or state regulatory authority for any violations of federal or state securities laws.

November 29, 2021

Page 3

In Counsel's opinion based on the Issuer's OTC filings and after inquiry of management and the directors of the Issuer, the Issuer is not currently a "shell company" as defined in Rule 405 of the Securities Act and section 12b-2 of the Exchange Act and has never in the past been a "shell company".

Counsel is opining herein as to the United States federal securities laws, and expresses no opinion with respect to the applicability thereto, or the effect thereon, of the laws of any other jurisdiction or as to any matters of municipal law or the laws of any local agencies within any state. In addition, the opinions expressed in this Letter are given as of the date of this Letter and Counsel disclaims any obligation to advise OTC Markets of any change in any matter set forth herein.

No person other than OTC Markets is entitled to rely on this Letter in determining whether the Issuer has made adequate current information publicly available within the meaning of Rule 144(c)(2) under the Securities Act. However, in connection therewith, OTC Markets is granted permission to publish the Letter through the OTC Disclosure & News Service for public viewing.

Sincerely,

Claire E. Brown

CEB/jl

042481000112907370v1